PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA. shelli.farhadian@yale.edu.\', \'Department of Neurology, Yale School of Medicine, New Haven, CT, 06510, USA. shelli.farhadian@yale.edu.\', \'Department of Internal Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.\', \'Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.\', \'Department of Neurology, Yale School of Medicine, New Haven, CT, 06510, USA.\', \'Isoplexis, Branford, CT, 06540, USA.\', \'Department of Internal Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, 06510, USA.\', \'Department of Internal Medicine, Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.\', \'Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s12883-020-01812-2
?:doi
?:hasPublicationType
?:journal
  • BMC neurology
is ?:pmid of
?:pmid
?:pmid
  • 32552792
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.006
?:rankingScore_hIndex
  • 59
is ?:relation_isRelatedTo_publication of
?:title
  • Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all